Absence of viral escape within a frequently recognized HLA-A26-restricted CD8 T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site Free

Abstract

CD8 T-cell responses are central for the resolution of hepatitis C virus (HCV) infection, and viral escape from these CD8 T-cell responses has been suggested to play a major role in HCV persistence. However, the factors determining the emergence of CD8 escape mutations are not well understood. Here, the first identification of four HLA-A26-restricted CD8 T-cell epitopes is reported. Of note, two of these four epitopes are located in the NS3/4A and NS5A/5B cleavage sites. The latter epitope is targeted in all (three of three) patients with acute, resolving HCV infection and in a relatively high proportion (four of 14) of patients with chronic HCV infection. Importantly, the epitope corresponding to the NS5A/5B cleavage site is characterized by the complete absence of sequence variations, despite the presence of functional virus-specific CD8 T cells in our cohort. These results support previous findings that showed defined functional constraints within this region. They also suggest that the absence of viral escape may be determined by viral fitness cost and highlight an attractive target for immunotherapies.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82826-0
2007-07-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/7/1986.html?itemId=/content/journal/jgv/10.1099/vir.0.82826-0&mimeType=html&fmt=ahah

References

  1. Altman J. D., Feinberg M. B. 2004; HIV escape: there and back again. Nat Med 10:229–230 [CrossRef]
    [Google Scholar]
  2. Bartenschlager R., Ahlborn-Laake L., Yasargil K., Mous J., Jacobsen H. 1995; Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. J Virol 69:198–205
    [Google Scholar]
  3. Bowen D. G., Walker C. M. 2005a; Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436:946–952 [CrossRef]
    [Google Scholar]
  4. Bowen D. G., Walker C. M. 2005b; Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J Exp Med 201:1709–1714 [CrossRef]
    [Google Scholar]
  5. Chang K. M., Rehermann B., McHutchison J. G., Pasquinelli C., Southwood S., Sette A., Chisari F. V. 1997; Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest 100:2376–2385 [CrossRef]
    [Google Scholar]
  6. Cox A. L., Mosbruger T., Mao Q., Liu Z., Wang X. H., Yang H. C., Sidney J., Sette A., Pardoll D. other authors 2005; Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201:1741–1752 [CrossRef]
    [Google Scholar]
  7. Erickson A. L., Kimura Y., Igarashi S., Eichelberger J., Houghton M., Sidney J., McKinney D., Sette A., Hughes A. L., Walker C. 2001; The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15:883–895 [CrossRef]
    [Google Scholar]
  8. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. 1993; Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol 67:2832–2843
    [Google Scholar]
  9. Grakoui A., Shoukry N. H., Woollard D. J., Han J. H., Hanson H. L., Ghrayeb J., Murthy K. K., Rice C. M., Walker C. M. 2003; HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659–662 [CrossRef]
    [Google Scholar]
  10. Kantzanou M., Lucas M., Barnes E., Komatsu H., Dusheiko G., Ward S., Harcourt G., Klenerman P. 2003; Viral escape and T cell exhaustion in hepatitis C virus infection analysed using class I peptide tetramers. Immunol Lett 85:165–171 [CrossRef]
    [Google Scholar]
  11. Kolykhalov A. A., Agapov E. V., Rice C. M. 1994; Specificity of the hepatitis C virus NS3 serine protease: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing. J Virol 68:7525–7533
    [Google Scholar]
  12. Kuiken C., Yusim K., Boykin L., Richardson R. 2005; The Los Alamos hepatitis C sequence database. Bioinformatics 21:379–384 [CrossRef]
    [Google Scholar]
  13. Lauer G. M., Barnes E., Lucas M., Timm J., Ouchi K., Kim A. Y., Day C. L., Robbins G. K., Casson D. R. other authors 2004; High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127:924–936 [CrossRef]
    [Google Scholar]
  14. Lechner F., Wong D. K., Dunbar P. R., Chapman R., Chung R. T., Dohrenwend P., Robbins G., Phillips R., Klenerman P., Walker B. D. 2000; Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191:1499–1512 [CrossRef]
    [Google Scholar]
  15. McKiernan S. M., Hagan R., Curry M., McDonald G. S., Kelly A., Nolan N., Walsh A., Hegarty J., Lawlor E., Kelleher D. 2004; Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40:108–114
    [Google Scholar]
  16. Meyer-Olson D., Shoukry N. H., Brady K. W., Kim H., Olson D. P., Hartman K., Shintani A. K., Walker C. M., Kalams S. A. 2004; Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med 200:307–319 [CrossRef]
    [Google Scholar]
  17. Neumann-Haefelin C., McKiernan S., Ward S., Viazov S., Spangenberg H. C., Killinger T., Baumert T. F., Nazarova N., Sheridan I. other authors 2006; Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 43:563–572 [CrossRef]
    [Google Scholar]
  18. Ray S. C., Fanning L., Wang X. H., Netski D. M., Kenny-Walsh E., Thomas D. L. 2005; Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 201:1753–1759 [CrossRef]
    [Google Scholar]
  19. Ruppert J., Sidney J., Celis E., Kubo R. T., Grey H. M., Sette A. 1993; Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929–937 [CrossRef]
    [Google Scholar]
  20. Seifert U., Liermann H., Racanelli V., Halenius A., Wiese M., Wedemeyer H., Ruppert T., Rispeter K., Henklein P. other authors 2004; Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest 114:250–259 [CrossRef]
    [Google Scholar]
  21. Soderholm J., Ahlen G., Kaul A., Frelin L., Alheim M., Barnfield C., Liljestrom P., Weiland O., Milich D. R. other authors 2006; Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 55:266–274 [CrossRef]
    [Google Scholar]
  22. Spangenberg H. C., Viazov S., Kersting N., Neumann-Haefelin C., McKinney D., Roggendorf M., von Weizsacker F., Blum H. E., Thimme R. 2005; Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 42:828–837 [CrossRef]
    [Google Scholar]
  23. Timm J., Lauer G. M., Kavanagh D. G., Sheridan I., Kim A. Y., Lucas M., Pillay T., Ouchi K., Reyor L. L. other authors 2004; CD8 epitope escape and reversion in acute HCV infection. J Exp Med 200:1593–1604 [CrossRef]
    [Google Scholar]
  24. Urbani S., Boni C., Missale G., Elia G., Cavallo C., Massari M., Raimondo G., Ferrari C. 2002; Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol 76:12423–12434 [CrossRef]
    [Google Scholar]
  25. Urbani S., Amadei B., Cariani E., Fisicaro P., Orlandini A., Missale G., Ferrari C. 2005; The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection. J Immunol 175:7519–7529 [CrossRef]
    [Google Scholar]
  26. Wedemeyer H., He X. S., Nascimbeni M., Davis A. R., Greenberg H. B., Hoofnagle J. H., Liang T. J., Alter H., Rehermann B. 2002; Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169:3447–3458 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82826-0
Loading
/content/journal/jgv/10.1099/vir.0.82826-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed